James B DuHadaway

5PUBLICATIONS
14CO-AUTHORS
AutoimmunityMolecular targetsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Dec 30, 2021
The Immunomodulatory Enzyme IDO2 Mediates Autoimmune Arthritis through a Nonenzymatic Mechanism.

Lauren M F Merlo, Weidan Peng, James B DuHadaway

|Aug 20, 2021
The FDA-Approved Anthelmintic Pyrvinium Pamoate Inhibits Pancreatic Cancer Cells in Nutrient-Depleted Conditions by Targeting the Mitochondria.

Christopher W Schultz, Grace A McCarthy, Teena Nerwal

|Feb 24, 2021
IDO1 Signaling through GCN2 in a Subpopulation of Gr-1+ Cells Shifts the IFNγ/IL6 Balance to Promote Neovascularization.

Souvik Dey, Arpita Mondal, James B DuHadaway

|Sep 09, 2017
RhoB blockade selectively inhibits autoantibody production in autoimmune models of rheumatoid arthritis and lupus.

Laura Mandik-Nayak, James B DuHadaway, Jennifer Mulgrew

|May 17, 2016
IDO2 Modulates T Cell-Dependent Autoimmune Responses through a B Cell-Intrinsic Mechanism.

Lauren M F Merlo, James B DuHadaway, Samantha Grabler

Pageof 1